Nantahala Capital Management »

Neurogene shares owned by Nantahala Capital Management

Quarter-by-quarter ownership of Neurogene (NGNE) shares owned by Nantahala Capital Management from 13F filings

Historical chart of Nantahala Capital Management investment in Neurogene

Tip: Access up to 7 years of quarterly data

All positions including Neurogene held by Nantahala Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Neurogene by Nantahala Capital Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $1.4M 72k 19.38

More positions owned by Nantahala Capital Management

Spdr Ser Tr S&p Biotech Put Option (XBI)
Spdr Ser Tr S&p Biotech Put Option (XBI)
Ishares Tr Russell 2000 Etf (IWM)
Ishares Tr Russell 2000 Etf (IWM)
Soleno Therapeutics (SLNO)
Soleno Therapeutics (SLNO)
Establishment Labs Holdings Ord (ESTA)
Establishment Labs Holdings Ord (ESTA)
Meta Financial (CASH)
Meta Financial (CASH)
Costco Wholesale Corporation Put Option (COST)
Costco Wholesale Corporation Put Option (COST)
Imax Corp Cad (IMAX)
Imax Corp Cad (IMAX)
Hilton Grand Vacations (HGV)

View all positions for Nantahala Capital Management

Top funds holding Neurogene

EcoR1 Capital
Samsara BioCapital
Dr. Jeffrey R. Jay, M.D.
Redmile Group
Henderson Group
Cormorant Asset Management
Arrowpoint Asset Management
Casdin Capital
Avidity Partners Management
Baker Bros. Advisors
Walleye Trading Advisors
Nantahala Capital Management
Vanguard Group
Bank of America Corporation
Bessemer

View all funds holding Neurogene